CIK 0001612042
- Large accelerated filer
Ascendis Pharma A/S
Sign in to watch- Ticker
- ASND
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Denmark
- Entity type
- Other
- Phone
- +45 70222244
- Business address
- TUBORG BOULEVARD 12, HELLERUP, Denmark
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $6,150,625
- in 3 filings
Net −$6,150,625. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-06-02 | SMITH SCOTT THOMAS EVP & Chief Financial Officer | Purchase | +100 | $219.00 | $22K | 4,367 |
| 2026-05-29 | SMITH SCOTT THOMAS EVP & Chief Financial Officer | Purchase | +250 | $223.32 | $56K | 4,267 |
Page 1 of 1 · 2 trades